Bergwerf, Herman. “Methylphenidate.” MolView, molview.org/?cid=4158.
Bossart, Mike. A2-Level Chemistry. Coordination Group Publications, 2005.
DrugBank. “Methylphenidate.” DrugBank, DrugBank, 16 Dec. 2018, 23:30, www.drugbank.ca/drugs/DB00422. Originally published: 13 June 2005, 07:24
Foist, Laura. “How a Compound’s Chemical Structure Affects Its Properties.” Study.com, Study.com, study.com/academy/lesson/how-a-compounds-chemical-structure-affects-its-properties.html.
“Geometry of Molecules.” Chemistry LibreTexts, National Science Foundation, 12 Dec. 2018, chem.libretexts.org/Textbook_Maps/Physical_and_Theoretical_Chemistry_Textbook_Maps/Supplemental_Modules_(Physical_and_Theoretical_Chemistry)/Chemical_Bonding/Lewis_Theory_of_Bonding/Geometry_of_Molecules.
Gottlieb, Scott. “Methylphenidate Works by Increasing Dopamine Levels.” NCBI, US National Library of Medicine National Institutes of Health, 3 Feb. 2001, www.ncbi.nlm.nih.gov/pmc/articles/PMC1119521/.
“How Do Bonding and Structure Affect Properties of Materials? – OCR 21C.” BBC News, BBC, www.bbc.com/bitesize/guides/z8kgqhv/revision/1.
Hughes, et al. “Project: Chemical Bonding in Man-Made Materials.” 3 Dec. 2018. https://docs.google.com/document/d/1VYq3ihkC06mH1BEH7Tg1i1qqTztG0uU7f1sipOfvH7I/edit.
“Levels of Solubility.” Solubility of Things, 2018, www.solubilityofthings.com/levels-of-solubility.
“Methylphenidate Abuse.” Edited by Amanda Lautieri and Patrick Condron, DrugAbuse.com, Recovery Brands LLC, a Subsidiary of American Addiction Centers, Inc., 28 Jan. 2016, drugabuse.com/library/methylphenidate-abuse/.
Morton, W A, and G G Stockton. “Methylphenidate Abuse and Psychiatric Side Effects.” NCBI, U.S. National Library of Medicine, Oct. 2000, www.ncbi.nlm.nih.gov/pubmed/15014637.
Mueller, Anna K., et al. “Stigma in Attention Deficit Hyperactivity Disorder.” NCBI, U.S. National Library of Medicine, 8 July 2012, www.ncbi.nlm.nih.gov/pmc/articles/PMC3430836/.
National Center for Biotechnology Information. PubChem Compound Database; CID=4158, https://pubchem.ncbi.nlm.nih.gov/compound/4158.
“Neurotypical.” Merriam-Webster, Merriam-Webster, www.merriam-webster.com/dictionary/neurotypical.
Robbins, Trevor W. “ADHD and Addiction.” Nature News, Nature Publishing Group, 1 Jan. 2002, www.nature.com/articles/nm0102-24.
Robinson, William R., et al. “Chemistry.” Introduction to Sociology – 1st Canadian Edition, BCcampus, https://opentextbc.ca/chemistry/chapter/7-6-molecular-structure-and-polarity/.
Rodden, Janice. “Methylphenidate.” ADDitude, ADDitude, 23 Mar. 2018, www.additudemag.com/medication/methylphenidate/.
Silver, Larry. “The Neuroscience of the ADHD Brain.” ADDitude, ADDitude, 11 Sept. 2018, www.additudemag.com/neuroscience-of-adhd-brain/.
“Stimulant ADHD Medications: Methylphenidate and Amphetamines.” National Institute on Drug Abuse, National Institute on Drug Abuse (NIH), Jan. 2014, www.drugabuse.gov/sites/default/files/drugfacts_stimulantadhd_1.pdf.
Storebø, Ole Jakob, et al. “Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Cochrane Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomised Clinical Trials.” British Medical Journal (BMJ), British Medical Journal (BMJ), 25 Nov. 2015, www.bmj.com/content/bmj/351/bmj.h5203.full.pdf.
“The Synapse.” Khan Academy, Khan Academy, 2016, www.khanacademy.org/science/biology/human-biology/neuron-nervous-system/a/the-synapse.
“Topics in the June 2012 Exam Paper for CHEM1611.” Faculty of Science – The University of Sydney, June 2012, scilearn.sydney.edu.au/fychemistry/chem1611/exam_answers/June2012_with_topics.pdf.
“Treatment: Attention Deficit Hyperactivity Disorder (ADHD).” NHS Choices, NHS, 30 May 2018, www.nhs.uk/conditions/attention-deficit-hyperactivity-disorder-adhd/treatment/.
Wilbraham, Antony C., et al. Pearson Chemistry. Pearson, 2017.
"C"-ing ADHD 